| Comparison of hepatocellular carcinoma in E astern versus W estern populations SP Choo, WL Tan, BKP Goh, WM Tai, AX Zhu Cancer 122 (22), 3430-3446, 2016 | 277 | 2016 |
| Novel therapeutic targets on the horizon for lung cancer WL Tan, A Jain, A Takano, EW Newell, NG Iyer, WT Lim, EH Tan, W Zhai, ... The Lancet Oncology 17 (8), e347-e362, 2016 | 202 | 2016 |
| Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer GGY Lai, TH Lim, J Lim, PJR Liew, XL Kwang, R Nahar, ZW Aung, ... Journal of clinical oncology 37 (11), 876-884, 2019 | 112 | 2019 |
| Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost … AC Tan, GGY Lai, G San Tan, SY Poon, B Doble, TH Lim, ZW Aung, ... Lung Cancer 139, 207-215, 2020 | 109 | 2020 |
| Advances in systemic treatment for nasopharyngeal carcinoma WL Tan, EH Tan, DWT Lim, QS Ng, DSW Tan, A Jain, MK Ang Chinese clinical oncology 5 (2), 21-21, 2016 | 81 | 2016 |
| EGFR mutation subtypes influence survival outcomes following first-line gefitinib therapy in advanced Asian NSCLC patients N Sutiman, SW Tan, EH Tan, WT Lim, R Kanesvaran, QS Ng, A Jain, ... Journal of Thoracic Oncology 12 (3), 529-538, 2017 | 66 | 2017 |
| Asian thoracic oncology research group expert consensus statement on optimal management of stage III NSCLC WL Tan, KLM Chua, CC Lin, VHF Lee, LM Tho, AW Chan, GF Ho, ... Journal of Thoracic Oncology 15 (3), 324-343, 2020 | 47 | 2020 |
| Molecular characterization and clinical outcomes in RET-rearranged NSCLC AC Tan, AOL Seet, GGY Lai, TH Lim, AST Lim, G San Tan, A Takano, ... Journal of Thoracic Oncology 15 (12), 1928-1934, 2020 | 35 | 2020 |
| Association of clinicopathologic and molecular tumor features with recurrence in resected early-stage epidermal growth factor receptor–positive non–small cell lung cancer SPL Saw, S Zhou, J Chen, G Lai, MK Ang, K Chua, R Kanesvaran, QS Ng, ... JAMA Network Open 4 (11), e2131892-e2131892, 2021 | 33 | 2021 |
| Integrative profiling of T790M-negative EGFR-mutated NSCLC reveals pervasive lineage transition and therapeutic opportunities KP Chua, YHF Teng, AC Tan, A Takano, JJS Alvarez, R Nahar, N Rohatgi, ... Clinical Cancer Research 27 (21), 5939-5950, 2021 | 24 | 2021 |
| Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases WL Tan, QS Ng, C Lim, EH Tan, CK Toh, MK Ang, R Kanesvaran, A Jain, ... BMC cancer 18, 1-9, 2018 | 24 | 2018 |
| From presentation to paper: gender disparities in oncological research WPM Dijksterhuis, CI Stroes, WL Tan, S Ithimakin, A Calles, ... International journal of cancer 146 (11), 3011-3021, 2020 | 14 | 2020 |
| 266O Combination ipilimumab and nivolumab in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC): Updated efficacy and safety analysis of NCT03097939 HF Kao, MK Ang, QS Ng, DSW Tan, W Tan, T Rajasekaran, A Jain, ... Annals of Oncology 31, S1347, 2020 | 11 | 2020 |
| Clinical efficacy and biomarker analysis of dual PD-1/CTLA-4 blockade in recurrent/metastatic EBV-associated nasopharyngeal carcinoma DWT Lim, HF Kao, L Suteja, CH Li, HS Quah, DSW Tan, SH Tan, EH Tan, ... Nature Communications 14 (1), 2781, 2023 | 10 | 2023 |
| Clinical and Genomic Features of HER2 Exon 20 Insertion Mutations and Characterization of HER2 Expression by Immunohistochemistry in East Asian Non–Small … AC Tan, SPL Saw, J Chen, GGY Lai, HN Oo, A Takano, DPX Lau, ... JCO Precision Oncology 6, e2200278, 2022 | 10 | 2022 |
| P1. 17-07 Neoadjuvant gefitinib in resectable early stage EGFR mutant non-small cell lung cancer (NSCLC): a window-of-opportunity study A Tan, KP Chua, A Takano, J Alvarez, BH Ong, T Koh, ZW Aung, A Jain, ... Journal of Thoracic Oncology 14 (10), S609-S610, 2019 | 9 | 2019 |
| The continuing role of epidermal growth factor receptor tyrosine kinase inhibitors in advanced squamous cell carcinoma of the lung WL Tan, QS Ng Translational Lung Cancer Research 5 (1), 106, 2016 | 8 | 2016 |
| PD-L1 score as a prognostic biomarker in asian early-stage epidermal growth factor receptor-mutated lung cancer SPL Saw, WP Ng, S Zhou, GGY Lai, AC Tan, MK Ang, WT Lim, ... European Journal of Cancer 178, 139-149, 2023 | 7 | 2023 |
| A randomized phase 2 trial of nivolumab versus nivolumab-ipilimumab combination in EGFR-mutant NSCLC GGY Lai, JC Yeo, A Jain, S Zhou, M Pang, JJS Alvarez, NL Sim, AC Tan, ... JTO Clinical and Research Reports 3 (12), 100416, 2022 | 7 | 2022 |
| Real world data on epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) use in advanced/metastatic non-small cell lung cancer (NSCLC) with EGFR mutations in … B Chua, EH Tan, DWT Lim, MK Ang, DSW Tan, QS Ng, R Kanesvaran, ... Annals of Oncology 29, ix161, 2018 | 7 | 2018 |
